FIRST POST PANDEMIC STUDY OF ITS KIND PROVIDES OBJECTIVE DATA TO HELP LIFE SCIENCE COMPANIES MAKE INFORMED DECISIONS ABOUT HOW AND WHERE EMPLOYEES SHOULD WORK

Home / Intelligence / News / FIRST POST PANDEMIC STUDY OF ITS KIND PROVIDES OBJECTIVE DATA TO HELP LIFE SCIENCE COMPANIES MAKE INFORMED DECISIONS ABOUT HOW AND WHERE EMPLOYEES SHOULD WORK

Webinar Entitled “Reimagining Work Models in the Life Sciences: Implications for the Future of Work” Will be Held on June 23


Waltham, MA, June 21, 2022 Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its latest TGaS report entitled, Reimagining Work Models in the Life Sciences: Implications for the Future of Work. The study is the first of its kind for the life sciences industry as it provides objective data to help companies make informed decisions about how and where employees should work. The paper finds that remote working did not have any negative impact on perceived achievement of intended outcomes. In fact, employees rated achievement of intended work outcomes 16% higher when working remotely/virtually and positive impact on work-life balance, development, autonomy, connectedness and contribution was rated up to 54% higher.

The study also reveals that collaborating using mixed live/virtual channels contributes to lowest outcomes and personal impact factors.

“This is an exciting opportunity for life sciences companies to be more intentional about future work-model decisions and policies and take a test-and-learn approach to designing work for functional teams. We’re learning so much about how to meet business targets while also optimizing retention and recruitment goals,” said Kristin Scott, Executive Director, Learning and Development Solution, TGaS Advisors, a Division of Trinity.

The study is based on the responses of 20 full-time Commercial Operations employees at a pharmaceutical company over a five-month period, with a total of 545 unique survey submissions. The survey data was compared to additional data collected from commercial employees at other life science companies in the TGaS member network. More than 10,000 data points are represented in the study findings.

On June 23rd at 1:00 p.m. – 1:45 p.m. ET, Trinity is hosting a webinar entitled Reimagining Work Models in the Life Sciences that will be presented by Kristin Scott, Executive Director, Learning and Development Solution, TGaS Advisors, a Division of Trinity. Topics include:

  • The changing work model for life sciences
  • Key findings that inform work-model policy decisions
  • Redesigning the future of work for Commercial Operations in life sciences

Life Science executives can attend the webinar by clicking here.

Media interested in attending the webinar can contact Elizabeth Marshall, emarshall@trinitylifesciences.com.


About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.